Sign in
NHWK Stock Price, Chart, Stats & News
NightHawk Biosciences, Inc.
Save
10.78M
Market cap
–
Current P/E
–
Forward P/E
NHWK chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 21.50% |
Operating margin | -2296.28% |
Pretax margin | -1206.45% |
Net margin | -1107.34% |
Effective tax rate | 8.22% |
ROA | -24.38% |
ROE | 531.02% |
D/E | -13.62x |
Interest coverage ratio | 29.88x |
NHWK valuation
P/E | – |
P/S | 0.00x |
P/B | -0.00x |
P/CF | -0.00x |
P/FCF | -0.00x |
P/OCF | -0.00x |
PEG | -0.00x |
EV multiple | 1.67x |
About
NightHawk Biosciences, Inc. operates as an integrated biopharmaceutical firm, dedicated to advancing immune therapies and vaccines. Their core mission involves leveraging and modifying the body's immune system to combat a range of illnesses, particularly various cancers and infectious diseases. Central to their strategy is the proprietary gp96 platform.
Similar securities
Based on sector and market capitalization
Report issue